Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
Alan Rembach, Noel G Faux, Andrew D Watt, Kelly K Pertile, Rebecca L Rumble, Brett O Trounson, Christopher J Fowler, Blaine R Roberts, Keyla A Perez, Qiao-Xin Li, Simon M Laws, Kevin Taddei, Stephanie Rainey-Smith, Joanne S Robertson, Manu Vandijck, Hugo Vanderstichele, Kevin J Barnham, Kathryn A Ellis, Cassandra Szoeke, Lance Macaulay Show all
Alzheimers Dement | ELSEVIER SCIENCE INC | Published : 2014
Related Projects (1)
Core funding for the study was provided by CSIRO, which was supplemented by in-kind contributions from the study partners (aibl.csiro.au). The research was also supported by the Science Industry and Endowment Fund (sief.org.au) and the National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program (DCRC2). The Mental Health Research Institute acknowledges the funding support from the Victorian government's Operational Infrastructure Support program. Pfizer International has contributed financial support to assist with analysis of blood samples and to further the Australian Imaging Biomarkers and Lifestyle research program. Alzheimer's Australia (Victoria and Western Australia) assisted with promotion of the study and the screening of telephone calls from volunteers. We thank Innogenetics-Fujirebio (Ghent, Belgium) for partially supporting the costs of the INNO-BIA immunoassay kits used in this study.